One definitive information is the company failed to "restore" its share price and share holder's confidence through reporting solid progress, so its management resorts to reverse split. The fact is its share price dropped ten percent in the first day after reverse split.
- Forums
- ASX - By Stock
- ATH
- Investigating the activity spectrum for ring-substituted 8-hydroxyquinolines.
Investigating the activity spectrum for ring-substituted 8-hydroxyquinolines., page-32
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.3¢ | 0.4¢ | 0.3¢ | $9.838K | 3.277M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
75 | 100044686 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 157644647 | 64 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
75 | 100044686 | 0.002 |
26 | 140640147 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 156344647 | 62 |
0.005 | 8366584 | 12 |
0.006 | 16581534 | 13 |
0.007 | 52264874 | 24 |
0.008 | 37620994 | 28 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online